Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Demonstrates In Vivo Dose-Dependent Efficacy and High Tolerability With a CRN-Substituted miRNA Antagonist

BOTHELL, WA--(Marketwire - Oct 19, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported in vivo dose-dependent efficacy with...
October 17, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Announces a $15 Million Purchase Agreement With Lincoln Park Capital Fund, LLC

BOTHELL, WA--(Marketwire - Oct 17, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it has entered into a...
September 08, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at the Rodman & Renshaw 13th Annual Healthcare Conference

BOTHELL, WA--(Marketwire - Sep 8, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it will present at the...
September 07, 2011 16:53 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Organizational Changes

BOTHELL, WA--(Marketwire - Sep 7, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, today announced organizational changes that...
September 01, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Nucleic Acid-Peptide Drug Delivery Platform

BOTHELL, WA--(Marketwire - Sep 1, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the U.S. Patent and...
August 11, 2011 16:05 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Announces Second Quarter 2011 Financial Results

BOTHELL, WA--(Marketwire - Aug 11, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNA-based drug discovery and development company, today reported financial results for the second quarter...
August 10, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Demonstrates In Vivo Knockdown of a microRNA With a CRN-Modified Antagomir

BOTHELL, WA--(Marketwire - Aug 10, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNA-based drug discovery and development company, reported in vivo data demonstrating up to 2.5-fold...
July 18, 2011 16:05 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Changes to Board of Directors

BOTHELL, WA--(Marketwire - Jul 18, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that R. John Fletcher was...
July 08, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Reports Significant Developments in Its Ability to Develop Both microRNA Mimetics and Antagonists

BOTHELL, WA--(Marketwire - Jul 8, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, reported data demonstrating that its proprietary...
June 09, 2011 08:35 ET | Source: Marina Biotech, Inc.

Marina Biotech Completes Dosing of First Cohort in the Phase 1b/2a START-FAP Clinical Trial of CEQ508

BOTHELL, WA--(Marketwire - Jun 9, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the completion of dosing for Cohort 1 in...